Increased soluble ICAM-1 and IL-6 are not speciofic plasma markers of endothelial dysfunction.
Blann
A D
AD
D015415:Biomarkers / Q000097:blood; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D006937:Hypercholesterolemia / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood* / Q000187:drug effects; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D011379:Prognosis; D012680:Sensitivity and Specificity; D012720:Severity of Illness Index; D012995:Solubility; D016896:Treatment Outcome
D015415:Biomarkers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D015850:Interleukin-6; D018799:Intercellular Adhesion Molecule-1